An investigator-sponsored pragmatic randomized controlled trial of AntiCoagulation vs AcetylSalicylic Acid after Transcatheter Aortic Valve Implantation: Rationale and design of ACASA-TAVI-Reference-Cited by-同舟云学术

An investigator-sponsored pragmatic randomized controlled trial of AntiCoagulation vs AcetylSalicylic Acid after Transcatheter Aortic Valve Implantation: Rationale and design of ACASA-TAVI

Published:2023-11 Issue: Volume:265 Page:225-232
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Dodgson Christopher S.,Beitnes Jan Otto,Kløve Sophie F.,Herstad Jon,Opdahl Anders,Undseth Ragnhild,Eek Christian H.,Broch Kaspar,Gullestad Lars,Aaberge Lars,Lunde Ketil,Bendz Bjørn,Lie Øyvind H.^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description;Cribier;Circulation,2002

2. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Writing Committee;J Am Coll Cardiol,2021

3. STS-ACC TVT registry of transcatheter aortic valve replacement;Carroll;J Am Coll Cardiol,2020

4. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves;Makkar;N Engl J Med,2015

5. Subclinical leaflet thrombosis in transcatheter and surgical bioprosthetic valves: PARTNER 3 cardiac computed tomography substudy;Makkar;J Am Coll Cardiol,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antithrombotic Treatment After Transcatheter Valve Interventions: Current Status and Future Directions;Clinical Therapeutics;2023-11